Rational medication use review: a quality assurance/improvement process for HIV/AIDS treatment programmes

Henry Fomundam, Andrew Maranga, Abraham Tesfay, Lucia Chanetsa, Vieira Muzola, Nkurabagaya Thierry, Henry Kambafwile

Abstract


Background: A Rational Medication Use Review (RMUR) was conducted at four facilities providing antiretroviral therapy in Burundi as a simple and practical strategy for service providers and programme managers to continuously assess and monitor quality of ART services provided.

Methods: A comprehensive data collection tool was developed to systematically and retrospectively capture relevant data from randomly selected ART patient files in the four ART facilities.

Results: ART data from 157 patients receiving ART services from four facilities was extracted and analysed. WHO stage 4 AIDS defining diseases were recorded in 125 (79.6%) of the patients at the time of ART initiation. The most frequent opportunistic infections and/or co-morbidities were cryptosporidiosis (14.4%), HIV wasting (14.4%), tuberculosis (13%) and candidiasis (17.4%). 97.8% of the patients were taking concomitant medicines. A large percentage of patients (72.4%) had done a baseline CD4 test before initiation of therapy with a majority of the patients (85.8%) getting their lab results within one week of the collection of the specimens. For some patients (9%), it took up to 8 weeks to get test results. About 21.8% of the patients were hospitalized at least once while on ART and 11.2% of the hospitalized patients died.

Conclusion: " RMUR is a simple and practical strategy that can be appropriately modified to suite local settings. It offers a cost-effective and participatory method of identifying and correcting factors that may negatively impact the quality of care and desired outcomes for patients on ART.

 


Keywords


Rational, Medication, Use, Antiretroviral, Therapy

Full Text:

PDF

References


The Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS report on the global AIDS epidemic. In: UNAIDS, eds. Global Report. India: UNAIDS; 2013.

WHO. HIV treatment access reaches over 1 million in sub-Saharan Africa. In: WHO, eds. WHO Reports. Geneva: WHO; 2006.

WHO. Global summary of the HIV/AIDS epidemic. In: WHO, eds. WHO Summary. Geneva: WHO; 2013.

United Nations. Political declaration on HIV/AIDS. In: UN, eds. Intensifying our Efforts to Eliminate HIV/AIDS. India: UN; 2011.

Hogg R, Yip B, Kully C, Craib K, O’Shaughnessy M, Schechter M, et al. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. Can Med Assoc J. 1999;160:659-65.

Williams B, Wood R, Dukay V, Delva W, Ginsburg D, Hargrove J, et al. Treatment as prevention: preparing the way. J Int AIDS Soc. 2011 Jul;14(Suppl 1):S6.

Brinkhof MWG, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86(7):497-576.

The Joint United Nations Programme on HIV/AIDS (UNAIDS). Treatment, 2015. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/JC2484_treatment-2015_en.pdf.

Massaquoi M, Zachariah R, Manzib M, Pasulani O, Misindi D, Mwagomba B, et al. Patient retention and attrition on antiretroviral treatment at district level in rural Malawi. Transact Royal Soc Trop Med Hyg. 2009;103:594-600.

Population Reference Bureau. World population data sheet, 2013. Available at: http://www.prb.org/pdf13/2013-population-data-sheet_eng.pdf.

UNAIDS. Burundi country progress report, 2012. Available at: http://www.unaids.org/sites/default/files/country/documents//ce_BI_Narrative_Report%5B1%5D.pdf.

HIV Insite. HIV/AIDS in Burundi, 2014. Available at: http://hivinsite.ucsf.edu/global?page=cr09-by-00 Accessed 01 December 2014.

Phillips MS. Drug use evaluation/medication use evaluation. In: DiPiro J, eds. Encyclopedia of Clinical Pharmacy. New York: Marcel Dekker, Inc.; 2002.

Gollogly L. Editorial: ethical approval for operational research. Bull World Health Organ. 2006;84(10):766.

National Institutes of Health. HPTN’ Initiation of antiretroviral treatment protects uninfected sexual partners from HIV infection (HPTN study 052’ Press release, 2001. Available at: http://www.avert.org/hiv-treatment-as-prevention.htm#footnote1_ff088my.

Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, Cohen CR, et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375(9731):2092-8.

Fomundam H, Mathews C. Antiretroviral therapy in South Africa. In: Fomundam H, Mathews C, eds. A Pocket Guide on Prevention and Management of Side Effects and Drug Interactions. 2nd ed. South Africa: The National Department of Health; 2009.

De Maat M, Ekhart G, Huitema A, Koks C, Mulder J, Beijnen J. Drug interactions between antiretroviral drugs and co-medicated agents. Clin Pharmacokin. 2003;42(3):223-82.

Patel P, Best B, Capparelli E. Paediatric antiretroviral pharmacology, 2005. http://sajhivmed.org.za/index.php/sajhivmed/article/viewFile/190/129. Accessed October 2014.

DHHS/HRSA. Guide for HIV/AIDS clinical care, 2014. Available at http://www.aidsetc.org/sites/default/files/resources_files/Clinical_Manual_4-30-2014_0.pdf. Accessed September 2014.

Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26:488-95.

Chesney MA. The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S149-55.

World Health Organization (WHO). Adherence to long term therapies - evidence for action, 2003. Available at: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf.

Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.

Fomundam H, King R. Remodeling pharmaceutical care in Sub-Saharan Africa amidst human resources challenges and the HIV/AIDS pandemic. Int J Health Plann Manage. 2010;25(1):30-48.